These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3726774)

  • 1. [Risks of contraception: vascular diseases].
    Genz HJ; Ludwig H
    Ther Umsch; 1986 May; 43(5):388-91. PubMed ID: 3726774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral contraceptives and nonfatal vascular disease.
    Porter JB; Hunter JR; Jick H; Stergachis A
    Obstet Gynecol; 1985 Jul; 66(1):1-4. PubMed ID: 4011060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contraceptive agents and cardiovascular diseases].
    Lisin N; Lambotte R; Remacle P
    Brux Med; 1977 Nov; 57(11):499-502. PubMed ID: 922541
    [No Abstract]   [Full Text] [Related]  

  • 5. The risks of oral contraception.
    McEwan J
    Br J Hosp Med; 1979 Feb; 21(2):144, 146, 148-50. PubMed ID: 465849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arterial complications of estrogen-progestogen contraception].
    Jaillard J
    Ann Med Interne (Paris); 1983; 134(5):416-20. PubMed ID: 6651062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and nonfatal vascular disease--recent experience.
    Porter JB; Hunter JR; Danielson DA; Jick H; Stergachis A
    Obstet Gynecol; 1982 Mar; 59(3):299-302. PubMed ID: 7078875
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].
    Herzog C; Mall-Haefeli M
    Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives. The current risk-benefit ratio.
    Connell EB
    J Reprod Med; 1984 Jul; 29(7 Suppl):513-23. PubMed ID: 6434735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraceptives and cardiovascular diseases].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Mar; 54():63-6. PubMed ID: 3721247
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraceptives and cardiovascular disease.
    Dalen JE; Hickler RB
    Am Heart J; 1981 May; 101(5):626-39. PubMed ID: 7223603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Major vascular complications during treatment with oral contraceptives and retrospective discovery of idiopathic hyperlipemia. 9 cases].
    de Gennes JL; Turpin G; Truffert J
    Presse Med (1893); 1970 Mar; 78(12):541-6. PubMed ID: 5439189
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic effects of oral contraceptives.
    Kelly TM
    West J Med; 1984 Jul; 141(1):113-6. PubMed ID: 6089441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic repercussions of oral contraception (author's transl)].
    Gaspard U
    J Pharm Belg; 1978; 33(5):312-24. PubMed ID: 745030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Status of oral contraceptives as a risk factor in cerebrovascular diseases].
    Auff E; Zeiler K; Holzner F; Wimmer S; Deecke L
    Wien Klin Wochenschr; 1986 May; 98(10):304-10. PubMed ID: 3727590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives: pharmacotherapy of normal women (author's transl)].
    Bühler FR
    Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic progestogens and phlebopathies].
    Degrassi R
    Minerva Med; 1971 Feb; 62(16):743-4. PubMed ID: 5549395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cardiovascular disease: some questions and answers.
    Vessey MP
    Br Med J (Clin Res Ed); 1982 Feb; 284(6316):615-6. PubMed ID: 6802257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.